Ketamine Treatment and Global Brain Connectivity in Major Depression
2016 · Neuropsychopharmacology · 299 citations
https://doi.org/10.1038/npp.2016.186
K
Katherine A. Collins
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
105
Papers
6.3K
Citations
34
h-index
50
i10-index
Katherine A. Collins is an academic researcher from Nathan Kline Institute for Psychiatric Research. The author has contributed to research in topics: Treatment of Major Depression & Obsessive-Compulsive Spectrum Disorders & Functional Brain Connectivity Studies. The author has an h-index of 34, co-authored 90 publications.
ORCID: 0000-0002-6717-879XPapers by this author
worksKetamine for rapid reduction of suicidal ideation: a randomized controlled trial
2015 · Psychological Medicine · 291 citations
https://doi.org/10.1017/s0033291715001506
Amino Acid Neurotransmitters Assessed by Proton Magnetic Resonance Spectroscopy: Relationship to Treatment Resistance in Major Depressive Disorder
2008 · Biological Psychiatry · 268 citations
https://doi.org/10.1016/j.biopsych.2008.10.025
Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression
2023 · New England Journal of Medicine · 235 citations
https://doi.org/10.1056/nejmoa2302399
Reduced global functional connectivity of the medial prefrontal cortex in major depressive disorder
2016 · Human Brain Mapping · 156 citations
https://doi.org/10.1002/hbm.23235
Regulation of neural responses to emotion perception by ketamine in individuals with treatment-resistant major depressive disorder
2015 · Translational Psychiatry · 109 citations
https://doi.org/10.1038/tp.2015.10
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat